10 min read·
Batch vs continuous vs cell-free biomanufacturing: throughput, cost, and quality compared
Comprehensive comparison of batch fermentation, continuous bioprocessing, and cell-free synthesis for commercial biomanufacturing. Continuous processes reduce production costs 20–40% at scale but require $10–50M more in automation infrastructure, while cell-free systems achieve 10x faster development cycles for high-value molecules under $1B annual market size.